Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of VZV-7D varicella vaccine in children aged 1-12 years
CTR20252239Phase 3Active
- Sponsor
- Wantai BioPharm
- Start
- Jun 2025
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of varicella virus vaccine live in chickenpox, sponsored by Wantai BioPharm. Started Jun 2025; status: active.
02
Drugs
varicella virus vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on CTR20252239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252239.